These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6169352

  • 21. Inhibition of Con A mitogenesis by serum from procainamide-treated patients and patients with systemic lupus erythematosus.
    Tannen RH, Cunningham-Rundles S.
    Immunol Commun; 1982; 11(1):33-45. PubMed ID: 6178682
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antinuclear antibody response to procainamide in man and laboratory animals.
    Whittingham S, Mackay IR, Whitworth JA, Sloman G.
    Am Heart J; 1972 Aug; 84(2):228-34. PubMed ID: 4538560
    [No Abstract] [Full Text] [Related]

  • 24. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA, Mulhern LM, Whiteside TL, Luksick J.
    J Rheumatol; 1980 Aug; 7(4):544-6. PubMed ID: 6999152
    [Abstract] [Full Text] [Related]

  • 25. Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.
    Ylitalo P, Ruosteenoja R, Leskinen O, Metsä-Ketelä T.
    Eur J Clin Pharmacol; 1983 Aug; 25(6):791-5. PubMed ID: 6198178
    [Abstract] [Full Text] [Related]

  • 26. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI, Thenot JP, Stec GP, Atkinson AJ.
    Ther Drug Monit; 1981 Aug; 3(3):231-7. PubMed ID: 6172888
    [Abstract] [Full Text] [Related]

  • 27. T lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay.
    Kubicka-Muranyi M, Goebels R, Goebel C, Uetrecht J, Gleichmann E.
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):88-94. PubMed ID: 7690998
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL, Lai CM, Gupta SD, Durrani MJ, Yacobi A.
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [Abstract] [Full Text] [Related]

  • 29. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.
    Svensson CK, Knowlton PW.
    Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808
    [Abstract] [Full Text] [Related]

  • 30. Lethal accumulation of procainamide metabolite in severe renal insufficiency.
    Vlasses PH, Ferguson RK, Rocci ML, Raja RM, Porter RS, Greenspan AM.
    Am J Nephrol; 1986 Jun; 6(2):112-6. PubMed ID: 2422935
    [Abstract] [Full Text] [Related]

  • 31. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes.
    Uetrecht JP, Sweetman BJ, Woosley RL, Oates JA.
    Drug Metab Dispos; 1984 Jun; 12(1):77-81. PubMed ID: 6141917
    [Abstract] [Full Text] [Related]

  • 32. Procainamide, NAPA and systemic lupus.
    Ahmad S.
    Circulation; 1980 Apr; 61(4):865-6. PubMed ID: 6153583
    [No Abstract] [Full Text] [Related]

  • 33. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
    Weisbart RH, Yee WS, Colburn KK, Whang SH, Heng MK, Boucek RJ.
    Ann Intern Med; 1986 Mar; 104(3):310-3. PubMed ID: 3511820
    [Abstract] [Full Text] [Related]

  • 34. Natural antibody to procainamide and procainamide-induced systematic lupus erythematosus.
    Russel AS, Ziff M.
    Ann Rheum Dis; 1969 May; 28(3):328. PubMed ID: 5305703
    [No Abstract] [Full Text] [Related]

  • 35. [Drug-induced lupus].
    Lovisetto P, Mairano D, Cargnino M, Biarese V, Marchi L, Lerda R.
    Recenti Prog Med; 1985 Feb; 76(2):110-7. PubMed ID: 2859642
    [No Abstract] [Full Text] [Related]

  • 36. Procainamide-induced systemic lupus erythematosus.
    Atkins CJ, Hamilton EB.
    Proc R Soc Med; 1969 Feb; 62(2):197-8. PubMed ID: 4180268
    [No Abstract] [Full Text] [Related]

  • 37. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus.
    Totoritis MC, Tan EM, McNally EM, Rubin RL.
    N Engl J Med; 1988 Jun 02; 318(22):1431-6. PubMed ID: 3259287
    [Abstract] [Full Text] [Related]

  • 38. Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome.
    Bluestein HG, Zvaifler NJ, Weisman MH, Shapiro RF.
    Lancet; 1979 Oct 20; 2(8147):816-9. PubMed ID: 90917
    [Abstract] [Full Text] [Related]

  • 39. Lupus erythematosus cells in pleural effusion: the initial manifestation of procainamide-induced lupus erythematosus.
    Carel RS, Shapiro MS, Shoham D, Gutman A.
    Chest; 1977 Nov 20; 72(5):670-2. PubMed ID: 71976
    [Abstract] [Full Text] [Related]

  • 40. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias.
    Giardina EG.
    Ann N Y Acad Sci; 1984 Nov 20; 432():177-88. PubMed ID: 6084435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.